Guidelines for the treatment of psoriatic arthritis with biologics
Guidelines for the treatment of psoriatic arthritis with biologics
Guidelines for the treatment of psoriatic arthritis with biologics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
60 Cecchi R, Bartoli L. Psoriasis and hepatitis C treated <strong>with</strong> anti‐TNF alpha <strong>the</strong>rapy (etanercept).<br />
Dermatol Online J 2006;12(7):4.<br />
61 De Simone C, Paradisi A, Capizzi R, Carbone A, Siciliano M, Amerio PL. Etanercept <strong>the</strong>rapy in two<br />
patients <strong>with</strong> psoriasis and concomitant hepatitis C. Journal <strong>of</strong> <strong>the</strong> American Academy <strong>of</strong> Dermatology<br />
2006;54(6):1102‐4.<br />
62 Furst DE, Keystone EC, Kirkham B, et al. Updated consensus statement on biological agents <strong>for</strong> <strong>the</strong><br />
<strong>treatment</strong> <strong>of</strong> rheumatic diseases, 2008. Ann Rheum Dis 2008;67 Suppl 3:iii2‐25.<br />
63 Nathan DM, Angus PW, Gibson PR. Hepatitis B and C virus infections and anti‐tumor necrosis factoralpha<br />
<strong>the</strong>rapy: guidelines <strong>for</strong> clinical approach. J Gastroenterol Hepatol 2006;21(9):1366‐71.<br />
64 Calabrese LH, Zein N, Vassilopoulos D. Safety <strong>of</strong> antitumour necrosis factor (anti‐TNF) <strong>the</strong>rapy in<br />
patients <strong>with</strong> chronic viral infections: hepatitis C, hepatitis B, and HIV infection. Ann Rheum Dis 2004;63 Suppl<br />
2:ii18‐ii24.<br />
65 Bartke U, Venten I, Kreuter A, Gubbay S, Altmeyer P, Brockmeyer NH. Human immunodeficiency<br />
virus‐associated psoriasis and <strong>psoriatic</strong> <strong>arthritis</strong> treated <strong>with</strong> infliximab.[Erratum appears in Br J Dermatol.<br />
2004 Jun;150(6):1235 Note: Gabbay, S [corrected to Gubbay, S]]. British Journal <strong>of</strong> Dermatology<br />
2004;150(4):784‐6.<br />
66 Cepeda EJ, Williams FM, Ishimori ML, Weisman MH, Reveille JD. The use <strong>of</strong> anti‐tumour necrosis<br />
factor <strong>the</strong>rapy in HIV‐positive individuals <strong>with</strong> rheumatic disease. Ann Rheum Dis 2008;67(5):710‐2.<br />
67 Linardaki G, Katsarou O, Ioannidou P, Karafoulidou A, Boki K. Effective etanercept <strong>treatment</strong> <strong>for</strong><br />
<strong>psoriatic</strong> <strong>arthritis</strong> complicating concomitant human immunodeficiency virus and hepatitis C virus infection. J<br />
Rheumatol 2007;34(6):1353‐5.<br />
68 Mikhail M, Weinberg JM, Smith BL. Successful <strong>treatment</strong> <strong>with</strong> etanercept <strong>of</strong> von Zumbusch pustular<br />
psoriasis in a patient <strong>with</strong> human immunodeficiency virus. Archives <strong>of</strong> dermatology 2008;144(4):453‐6.<br />
69 Sellam J, Bouvard B, Masson C, et al. Use <strong>of</strong> infliximab to treat <strong>psoriatic</strong> <strong>arthritis</strong> in HIV‐positive<br />
patients. Joint, Bone, Spine: Revue du Rhumatisme 2007;74(2):197‐200.<br />
70 Aboulafia DM, Bundow D, Wilske K, Ochs UI. Etanercept <strong>for</strong> <strong>the</strong> <strong>treatment</strong> <strong>of</strong> human<br />
immunodeficiency virus‐associated <strong>psoriatic</strong> <strong>arthritis</strong>. Mayo Clinic Proceedings 2000;75(10):1093‐8.<br />
71 Menon K, Van Voorhees AS, Bebo BF, Jr., et al. Psoriasis in patients <strong>with</strong> HIV infection: from <strong>the</strong><br />
medical board <strong>of</strong> <strong>the</strong> National Psoriasis Foundation. Journal <strong>of</strong> <strong>the</strong> American Academy <strong>of</strong> Dermatology<br />
2010;62(2):291‐9.<br />
72 Strober B, Berger E, Ca<strong>the</strong>r J, et al. A series <strong>of</strong> critically challenging case scenarios in moderate to<br />
severe psoriasis: A Delphi consensus approach. Journal <strong>of</strong> <strong>the</strong> American Academy <strong>of</strong> Dermatology 2009;61(1<br />
SUPPL. 1):S1‐S46.<br />
73 Mariette X, Matucci‐Cerinic M, Pavelka K, et al. Malignancies associated <strong>with</strong> tumour necrosis factor<br />
inhibitors in registries and prospective observational studies: a systematic review and meta‐analysis. Ann<br />
Rheum Dis 2011;70(11):1895‐904.<br />
74 Wolfe F, Michaud K. Biologic <strong>treatment</strong> <strong>of</strong> rheumatoid <strong>arthritis</strong> and <strong>the</strong> risk <strong>of</strong> malignancy: analyses<br />
from a large US observational study. Arthritis and rheumatism 2007;56(9):2886‐95.<br />
24
Change language